US 9120777
Heterocyclic compound
granted A61PA61P3/00A61P3/10
Quick answer
US patent 9120777 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P3/00, A61P3/10